- Home
- Personal stories
Personal stories
-
What you need to know about Johnson & Johnson’s 2020 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses. -
-
“I have never seen a moment so rich in collaboration, ingenuity and acts of bravery": Johnson & Johnson announces it has identified a lead COVID-19 vaccine candidate
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process. -
Johnson & Johnson announces a $50 million commitment to support frontline health workers battling COVID-19
The funds will be earmarked for assisting the doctors, nurses, midwives and community health workers who are working tirelessly to treat patients around the world during the novel coronavirus pandemic. -
“I was on the front lines of the COVID-19 outbreak in Wuhan": A doctor shares his story
Dr. Dongchen Zhou was a practicing cardiologist in Hangzhou, Zhejiang Province, China, when he received a call to help volunteer at a hospital in Wuhan. In February 2020 he began to treat COVID-19 patients—and recounts for us what his journey was like. -
-
Windows on the past: The Johnson & Johnson employees who were forever commemorated in stained glass
In the 1930s the company commissioned a series of colorful panels to pay homage to men and women who worked at Johnson & Johnson. For Employee Appreciation Day, we tell the story behind the art. -
-
The charming way Johnson & Johnson showed its thanks to employees in the 1960s
We posed a question to Johnson & Johnson’s Chief Historian: What artifact from the archives do you love best? -
What you need to know about Johnson & Johnson’s 2019 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth quarter and annual earnings report, with key performance highlights from its pharmaceutical, consumer and medical devices businesses.